CDK9 and endometrial cancer: Most of them, including CAN-508, LDC000067, SNS-032, and AZD-4573, produce CDK9 inhibition with IC50 values in the low nanomolar range, causing apoptosis and downregulation of MCL-1 in leukemia and in tumor cell lines (breast, osteosarcoma, ovarian cancer, prostate, melanoma, and endometrial cancers) [51].